Join Now

Category Archives: BioUtah News

BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics

BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics

| Tagged | Comments Off on BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics

Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO

Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO

| Tagged | Comments Off on Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO

CancerVax Launches $5 Million Funding Round

Proceeds from the SEC qualified Reg A+ offering will allow the Company to continue work on its breakthrough cancer treatments

| Tagged | Comments Off on CancerVax Launches $5 Million Funding Round

New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health

Dan Albertson, MD, will serve as president of the University Business Unit.

| Tagged | Comments Off on New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health

VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION

Varex Imaging has entered into a senior secured revolving credit agreement for an initial aggregate principal amount of up to $155 million.

| Tagged | Comments Off on VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION

New Survey Reveals Patients Receive Too Many Needlesticks

Most Americans Unaware of Challenges from Common Hospital Procedures

| Tagged | Comments Off on New Survey Reveals Patients Receive Too Many Needlesticks

BD Named Among Fortune’s Most Innovative Companies

BD Named Among Fortune’s Most Innovative Companies

| Tagged | Comments Off on BD Named Among Fortune’s Most Innovative Companies

Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

| Tagged | Comments Off on Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Pivotal Trial for Improving Overall Function and Quality of Life

| Tagged | Comments Off on PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®

Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®

| Tagged | Comments Off on Spectrum Solutions® Releases the New SimplyPERIO™ Saliva Test Powered by SimplyTest®

Seek Labs Appoints Renowned Life Sciences Innovator, Dr. Michael Paul, PhD, to Board of Directors

SALT LAKE CITY, UT, March 19, 2024 (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel CRISPR-based gene therapies, is pleased to announce the appointment of Michael Paul, PhD to its Board of Directors, effective March 18, 2024. With decades of experience in life sciences innovation, capital formation, […]

| Comments Off on Seek Labs Appoints Renowned Life Sciences Innovator, Dr. Michael Paul, PhD, to Board of Directors

Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

SALT LAKE CITY, March 21, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark Office has issued a patent that will strengthen its ability to deliver a tumor-informed, high-definition, molecular residual disease (MRD) assay to market. U.S. patent […]

| Comments Off on Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date